Clinical Development Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Clinical Development stocks.

Clinical Development Stocks Recent News

Date Stock Title
May 7 FGEN FibroGen to Participate in Upcoming Investor Conferences
May 7 FGEN FibroGen Inc (FGEN) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...
May 7 FGEN FibroGen, Inc. (FGEN) Q1 2024 Earnings Call Transcript
May 6 GMED Globus Medical Q1 2024 Earnings Preview
May 6 FGEN FibroGen GAAP EPS of -$0.33 beats by $0.20, revenue of $55.9M beats by $19.45M
May 6 FGEN FibroGen Reports First Quarter 2024 Financial Results
May 6 GMED Wall Street's Insights Into Key Metrics Ahead of Globus Medical (GMED) Q1 Earnings
May 6 BLRX BioLineRx Announces Poster Presentation on Economic Model Data for APHEXDA® (motixafortide) as part of CD34+ Hematopoietic Stem Cell Mobilization in Patients with Multiple Myeloma at ISPOR 2024
May 3 FGEN FibroGen Q1 2024 Earnings Preview
May 3 AUPH Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2024 Earnings Call Transcript
May 2 AUPH Aurinia Pharma: A Welcome Change To The Thesis (Rating Upgrade)
May 2 AUPH Aurinia Pharmaceuticals Inc. (AUPH) Q1 2024 Earnings Call Transcript
May 2 AUPH Aurinia Pharmaceuticals (AUPH) Reports Q1 Loss, Tops Revenue Estimates
May 2 AUPH Aurinia Pharma GAAP EPS of -$0.07 beats by $0.07, revenue of $50.3M beats by $3.23M
May 2 AUPH Aurinia Pharmaceuticals Reports First Quarter 2024 Financial and Operational Results
May 1 AUPH Aurinia Pharma Q1 2024 Earnings Preview
May 1 MORF Here's Why We're Not Too Worried About Morphic Holding's (NASDAQ:MORF) Cash Burn Situation
May 1 AUPH Aurinia Underscores Enduring Commitment to People Living with Lupus Nephritis Through Innovative Advocacy and Education Initiatives for Lupus Awareness Month
Apr 30 AUPH Aurinia: Updated Lupkynis Label Should Keep Sales Growth Momentum Going
Apr 30 AUPH Aurinia gains on Lupkynis label update
Clinical Development

Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.

Browse All Tags